| Tag | Content |
|---|
EnhancerAtlas ID | HS105-46017 |
Organism | Homo sapiens |
Tissue/cell | IMR90 |
Coordinate | chr2:161224290-161226310 |
| | Number of super-enhancer constituents: 14 | ID | Coordinate | Tissue/cell |
| SE_00195 | chr2:161223816-161240345 | Adipose_Nuclei | | SE_09538 | chr2:161221992-161226515 | CD14 | | SE_37046 | chr2:161220042-161238864 | HSMMtube | | SE_41233 | chr2:161224213-161225213 | Left_Ventricle | | SE_41233 | chr2:161225458-161226631 | Left_Ventricle | | SE_44249 | chr2:161219185-161226908 | NHDF-Ad | | SE_44825 | chr2:161224538-161225248 | NHLF | | SE_45573 | chr2:161219128-161240105 | Osteoblasts | | SE_51744 | chr2:161221533-161226805 | Skeletal_Muscle_Myoblast | | SE_53632 | chr2:161224253-161225363 | Spleen | | SE_53632 | chr2:161225565-161226220 | Spleen | | SE_55787 | chr2:161223639-161226716 | u87 | | SE_63532 | chr2:161220416-161228597 | HSMM | | SE_67731 | chr2:161223639-161226716 | u87 |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr2 | 161224347 | 161224963 | | chr2 | 161225244 | 161225298 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH02I160363 | chr2 | 161219912 | 161239431 |
|
Enhancer Sequence | TTGAAAGTTG CTTAAAATTT TATTAGGATG ACTCTTAAAA AAAATTACTT CTCAAGTACA 60
AGAAAGTTAG AGTTTAATCC AGATACTCCA ATAAGGACGA TCTCACCTAG TTCTAAGACA 120
GGCACACGAC TTCATTGAGA CATCTGGGTA AGATTCCCAG GCAGGCTGCC TTTCGCTCTG 180
GCTAACCTTG TGAAATTTAA CCCCTGTGAG AATGGTGTCC AAGCTGGAAA ACTTCCCAGC 240
TTGCAGCACC CACCACAACT CAAAGTAAAG CCTGCAACCA AAGGACTCAG TGTGGTTTTA 300
CAGTCGGCAG CCACCTAGGA AGAATGTCTG AAATTGTACT CATACCAGAT AATTCTCTGT 360
GCACCGACTG AAAGAAACCA CAGTTCTCTG ACCCAGTGCC ACACACATGA CTTTGAGGAA 420
GTTAAATGGC TCAGCTTGAG ACAAAAGGGC ACGTAACCCC AAGTGTCCTC ACAGCAAACG 480
CGCAGCAATT TCACACCAGG ACAGGGACGT TTTTTCACCT CACATTTTCT AAATCATAAA 540
TATACTGTAC TAACTCAAGG ACATCACTCA TGAACAGTTT GAACATCCAA AATTAAATAG 600
TCACTAGACA GTCAAAAGGT TCAAATCTCA TGGCTTGGTT TTTACCAGCA CAAACAAGAA 660
AGTCAGGCAT GTCTATAGGA GACAAATCAA ATCCCACAGT GGAAAGTTGG AGAAGCAGAC 720
CCCTTACAAT AAGCATATCC TCATTTACCT TGTCACCAAC CTCCGTTGCC CACTATAGAT 780
TCCTAGTTTT GTACCCAGCT TCTGCCATGG TCATCCTAAT TCCATAATAT CTCAACATAT 840
GGGGATCTCA TTAATTTATT TTTATTTTTT ATTATTTGAG ATGGAGTCTC GCTCTGTCAC 900
CCAGGCTGGA GTGCAGTGGT GCAATCTCGG CTCACCGGAA CCCTCCACCT CCCGGTTTCC 960
AGTGATTCTC TTGCCTCAGC CTCCTGAGGA GCTGGGATTA CAGACGCACA ACACCATGCC 1020
TGGCTAATTT TTGTATTTTT AGTAGAGACA GGGTTTCACC ATGTTGACCT GGCTGGTCTT 1080
GAACTCCAGA CCTCAGGTGA TCCGCTCAAC TCGGTTTCCC AAAGTGCTGG GATTACAGGC 1140
ATGAGCCATC GTGCCTGGCC CCATTAATTT AGATATGTTA CCATTTTTTC TGGTCCTATA 1200
TCCTTCAGAT TCTTCCTTCC ACTGCCCAGG TTCCTTGCTG AGATATCATC TGAGTCCAAA 1260
CACCACTTTA TTTAAAGAGA TTCTCTTTTA GAAGGAGAGC AGCAAAGGGT CAATAATAGT 1320
CAATGCAGAA ATGCTATTCA CTGAAGGCTG AACTTGAACT GGGAACATCG GTATTGCTTA 1380
ATCCCAAAAT AAAAGCAGCC TGAGATCATA TCCTACCAAA TCTATTTGAT TCATGCCCTT 1440
AATGAGCAGC TGAACTCATA TCCTTTCTCC AAACCACTAG TTTTTCTCTA GGGGCTAACT 1500
ACTTACTAGA TATAAAACTA AGACCAAATT CTGACACTTG CTCTGCCACA GGTGGCACCT 1560
CAGAGCACTG GCCATGCCCC ACAAAGCCTG TGCTCCTTCT CTGAAGCCAC TGAGTTGCTA 1620
CCTGCCATCC AGCCCTACTC TATTTTTCAC ATCAGTGAGA ACAGAGGTGC TGGAAAGTAG 1680
CCCACACACC TGCCTCCTGT CCCAAGCCTT TGATTGACGC AGAGAACTTG TAGCTATTAG 1740
AACTAGACAG GACTGAATTT TCTCTTAAAC CTCCTTTGAT TAGTGTCTCA GAAACCATCC 1800
CTGACACAAG CCACACTGTT TTCACAGTAG GACCCAGTAT GTTTAGCGTA GCTGTTGGGC 1860
GATGAAATGT GGTCATCTGG GATGAGACTT GGAGAAGTCA GTAAGAAGCT GTGGATCAGG 1920
CCCGCCCCTA CCTCTTAGTG GGATTACATC AACACGAAGT AAATGAACCA TCAGGCATTT 1980
TAAAGACTGC ATTCCAAGAC TGCATTCACT TGAACCTTTG 2020
|
